Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Metoclopramide for Acute Migraine in the ED
NCT02314351Phase 4Completed
- Sponsor
- Kocaeli University
- Start
- Dec 2014
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in migraine comparing Intravenous metoclopramide with Placebo (2 arms). Primary endpoint: Difference between pain scores at 30 months. Started Dec 2014; status: completed.
02
Drugs
metoclopramide
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02314351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02314351.